CNS Pharmaceuticals, Inc. reports

Company location: Houston, TX
Fiscal year end: 31 December

CNS Pharmaceuticals, Inc. has filed 389 SEC EDGAR filings since 13 Mar 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-21 of 21 matching filings.

Per page

25

Current page

1

10-Q File 001-39126

FORM 10-Q FOR JUN 2026

Filing date: 12 Aug 2026
Reporting date: 30 Jun 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR MAR 2026

Filing date: 14 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR SEP 2025

Filing date: 14 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUN 2025

Filing date: 14 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR MAR 2025

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR SEPT 2024

Filing date: 14 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUNE 2024

Filing date: 14 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR 3/31/24

Filing date: 15 May 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 10 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 13 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUNE 30, 2021

Filing date: 13 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 13 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Nov 2020
Reporting date: 30 Sep 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 10 Aug 2020
Reporting date: 30 Jun 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 15 May 2020
Reporting date: 31 Mar 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 20 Dec 2019
Reporting date: 30 Sep 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .